Get my own profile
Public access
View all1 article
0 articles
available
not available
Based on funding mandates
Co-authors
- Bernard BARLAAMDrVerified email at astrazeneca.com
- Franklin A. DavisProfessor Temple universityVerified email at temple.edu
- Claudio ChuaquiSyros PharmaceuticalsVerified email at syros.com
- Michelle L LambAstraZenecaVerified email at astrazeneca.com
- Huawei Ray ChenZentaur TherapeuticsVerified email at Zentaurtx.com
- Scott EdmondsonNimbus TherapeuticsVerified email at nimbustx.com
- James W. JanetkaProfessor, Washington University School of MedicineVerified email at wustl.edu
- Andrew FergusonTakeda PharmaceuticalsVerified email at takeda.com
- Richard A WardAstraZenecaVerified email at astrazeneca.com
- Frederick W GoldbergGlobal Project Leader (Senior Director), Oncology R&D, AstraZenecaVerified email at astrazeneca.com
- Dorin ToaderDirector at Mersana TherapeuticsVerified email at mersana.com
- Kirti SharmaSenior Director, Kymera Therapeutics, Cambridge, MA 02139Verified email at kymeratx.com
- Scott RusinPhotys TherapeuticsVerified email at dartmouth.edu
- Csibi AVerified email at infi.com
- Jason Grant KettlePrincipal Scientist, Medicinal Chemistry, Oncology iMED, AstraZenecaVerified email at astrazeneca.com
- Sebastien DegorceAstraZeneca
Follow
Bin Yang
Executive Director, Medicinal Chemistry, Kymera Therapeutics
Verified email at kymeratx.com